(Q24290719)

English

The antipoverty vaccines

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

The antipoverty vaccines (English)

0 references

1

0 references

author name string

Meghan T Ferris

2

0 references

language of work or name

0 references

publication date

26 July 2006

0 references

0 references

24

0 references

31-32

0 references

5787-99

0 references

The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The Millennium Project: a plan for meeting the Millennium Development Goals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Medicine. The need for a global HIV vaccine enterprise

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Malaria vaccine development: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The Development and Impact of Tuberculosis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Population ecology of intestinal helminth infections in human communities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Hookworm Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Evidence for an association between hookworm infection and cognitive function in Indonesian school children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Moderate to heavy infections ofTrichuris trichiuraaffect cognitive function in Jamaican school children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Worms: Identifying Impacts on Education and Health in the Presence of Treatment Externalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Extending the benefits of deworming for development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

New technologies for the control of human hookworm infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Schistosomes: the road from host-parasite interactions to vaccines in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Expressive and receptive language functioning in preschool children with prenatal cocaine exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Cognitive outcomes of preschool children with prenatal cocaine exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Development of immunopharmacotherapy against drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Malaria during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Hookworm infection in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Hookworm and anaemia prevalence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Schistosoma mansoni in pregnancy and associations with anaemia in northwest Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The effects of maternal helminth and malaria infections on mother-to-child HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Chagas disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Chagas' disease: study of congenital transmission in cases of acute maternal infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon- gamma in response to parasite antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Syphilis in children: congenital and acquired

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Mortality associated with congenital syphilis in the United States, 1992-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Visceral leishmaniasis (kala-azar) and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Maternal and perinatal outcome with drug abuse in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Adverse perinatal outcome in parturients who use crack cocaine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Reproductive risks of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Dracunculiasis eradication: the final inch.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Functional impairment caused by lymphatic filariasis in rural areas of south India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The economic burden of Kala-azar in households of the Danusha and Mahottari districts of Nepal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Economic evaluation of Mectizan distribution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The deadly hookworm. Why did the Puerto Ricans die?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Do intestinal nematodes affect productivity in adulthood?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Neglected diseases of neglected populations: thinking to reshape the determinants of health in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Achieving the Millennium Development Goals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Worms can worsen malaria: towards a new means to roll back malaria?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Fighting tropical diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Towards a recombinant antigen vaccine against Onchocerca volvulus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Future directions for vaccine-related onchocerciasis research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The genome of the protist parasite Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Comparative genomics of trypanosomatid parasitic protozoa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

From genome to vaccines for leishmaniasis: Screening 100 novel vaccine candidates against murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Recent progress in vaccines for amebiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

A virulence attenuated amoebapore-less mutant of Entamoeba histolytica and its interaction with host cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Immunotherapy of Trypanosoma cruzi infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

New approaches in vaccine development for parasitic infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The Trypanosoma cruzi proteome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Second-generation vaccines against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Genome and proteome analysis of Chlamydia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Genome scale identification of Treponema pallidum antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Prospects for vaccine development against Buruli disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

New steps toward eliminating blinding trachoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Delivery of Chlamydia vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Vaccines for sexually transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

The role of BCG in prevention of leprosy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Progress towards an effective syphilis vaccine: the past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

New developments in flavivirus vaccines with special attention to yellow fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Cost-effectiveness of a pediatric dengue vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Development of Orphan Vaccines: An Industry Perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Health Innovation Networks to Help Developing Countries Address Neglected Diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Priority setting and the 'neglected' tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of Chagas disease control in Latin America: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24290719&oldid=1417014337"